Global Oncology Information Systems Market - 2021-2028
|出版日期||內容資訊||英文 180 Pages
|腫瘤資訊系統的全球市場 (2021年∼2028年) Global Oncology Information Systems Market - 2021-2028|
|出版日期: 2021年06月01日||內容資訊: 英文 180 Pages||
The global oncology information systems market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).
Oncology information systems (OIS) are used to manage the data of cancer patient hospitalization programs, treatment deliveries, treatment plans, and diagnostic results. The OIS will enclose the information transfer with different departments inside the health care enterprise, and it must be connected to different hospitals' information systems. It will support the evaluation and improvement of treatment from information on cancer stage and treatment. OIS accredits increased medical safety and professional effectiveness. Several resources like paper-based (hospital registries), network, and others will help maintain oncology information at healthcare enterprise.
The oncology information systems market growth is driven by the increasing demand for IT services due to increasing prevalence of cancer cases is expected to fuel the growth of the oncology information systems market. It is advantageous over traditional data handling & validations, and it further decreased the manual effort and automated the process. The oncology information system has immense applicability in healthcare settings for better management of cancer patients.
The rising incidence of cancer worldwide will drive the market growth
The significant factors associating with the growth of the OIS market include the increasing incidence of cancer cases worldwide. A rise in the geriatric population also drives the demand for oncology information systems and drives market growth.
As per the Globocan 2020 fact sheet, an expected 19,292,789 new cancer cases were diagnosed worldwide, with approximately 9,958,133 deaths due to cancers globally. Additionally, according to estimates of the International Agency for Research on Cancer, by 2040, the global burden of cancers is anticipated to grow to 27.5 million new cancer cases and 16.3 million deaths worldwide.
Owing to the growing number of specific treatments in the oncology pipeline, the number of late-stage pipeline treatments rose from 711 in 2017 to 849 in 2018, an increase of 19% and the use of information systems help in maintaining the data of these treatments between the healthcare organization and treatment providers/patients are boosting the market growth.
Growing government initiatives for cancer awareness is driving the market growth
Governments worldwide are proposing reforms and introducing new regulations that would assist in the enterprise-wide and general adoption of information technologies, including OIS, which aid in the transmutation of healthcare systems. For instance, in the United States, the Health Information Technology for Economic and Clinical Health (HITECH) Act enacted under the American Recovery and Reinvestment Act allocated funding to incentivize hospital physicians to confirm meaningful use of EHRs. The availability of superior Healthcare IT solutions for cancer care generates significant interest among end-users due to the better treatment outcomes promised by them.
High cost of oncology information systems will hamper the market growth
The cost of OIS for various medical devices is considerably high. Affordability is an essential provocation for healthcare organizations, particularly in emerging countries, where it is challenging to obtain budgetary permissions for IT solutions over medical equipment. Smaller healthcare organizations strive to implement Internet connectivity to medical devices, primarily due to difficulties in executing various networks with health settings, wireless connectivity alternatives, and installing security layers to withdraw data breaches. In addition, the infrastructural expenses for performing an oncology information system and connecting it with different devices with different interfaces form a vital obstacle to market growth in emerging countries. The implementation and subscription fees for integration solutions are the vital financial burden and add to the budgetary woes faced by many hospitals.
COVID-19 Impact Analysis
Due to the pandemic, the access to customers to sell and implement the OIS reduced as hospitals became primarily focused on the COVID-19 patients. The pandemic has led to a significant reduction in the requirement for OIS. The pandemic has also influenced the oncology field since doctors cannot focus on regular patients since they are being redeployed for treating COVID-19 patients. Therefore, performing oncology surgery and treatment has become a significant challenge with the non-availability of hospital staff and operation facilities. Moreover, the market for OIS is expecting to recover the losses when the situation becomes normal.
By product & services, the oncology information systems market is classified into software ( patient information systems, treatment planning systems, reatment management systems & medical, image analysis systems), services (consulting/optimization services, implementation services, post-sale and maintenance services)
Software segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)
The software segment has dominated the market due to the increase in cancer patients globally and the tests associated with examining and treating cancer patients. According to GLOBOCAN 2018, there is an estimated 2,129,118 incident cases in the United States in 2018, which is expected to grow by 2040 and reach 3,096,944 cases. As the number of people with cancer increases, keeping track of patient data and coordinating treatment plans is challenging for doctors and medical professionals. Softwares of oncology information systems can help medical professionals track all the information related to patient and their treatment. The oncology information system software helps physicians to improve the management of patient information.
The patient information systems segment has the largest share in the software segment. A patient information system is a kind of clinical information system assigned to collecting, storing, manipulating, and making available clinical information crucial to the delivery of patient care. The primary focus of such systems is clinical data and not financial or billing data.
It also involves those systems that handle data related to the activities of providers and health organizations. As an integrated effort, these may be leveraged to improve patient outcomes, inform research, and influence policy-making and decision-making. Because health information systems commonly access, process, or maintain large volumes of sensitive data, security is a primary concern.
On the basis of application, the the oncology information systems market is classified into radiation oncology, medical oncology, surgical oncology.
The radiation oncology segment are expected to dominate the oncology information systems market during the forecast period
The radiation oncology segment expected a larger share of the market. The growing installation base for radiotherapy devices, the growing number of radiosurgery systems related to fractures, rapid growth in cancer-affected populations across the globe, and the expansion of advanced radiology information systems and radiation treatment planning systems are constituents expected to propel the growth of this market. For instance, according to the Organisation for Economic Co-operation and Development, in the U.S., the number of radiation oncology equipment increased from 11.5 in 2018 to 11.7 per 1000,000 inhabitants in 2019. These factors are driving the segment growth in the forecast period.
It is estimated that 145,483 Australians were diagnosed with cancer in 2020. The age-standardized percentage rate in 2020 is estimated to be 480 cases per 100,000 persons. In 2017, 24,453 cancers were recorded in New Zealand, at an age-standardized percentage rate of 331 per 100,000 people. It is estimated that about half of cancer patients will avail of radiation treatment due to their overall cancer therapy. Also, 1 in 2 patients with cancer may benefit from radiation oncology treatment at some point during their illness.
Radiation oncology treatment is a highly cost-effective cancer treatment. It requires less than 9 cents out of each healthcare dollar spent on treating cancer overall, yet it is essential in about 40% of all cured cancers. With cancer being the leading case of death worldwide, investment in developing radiation oncology treatments, helping cancer patients access radiation therapy and building new treatment centers have never been more critical.
North America region holds the largest market share in the global Oncology Information Systems market
North America region is dominating the global oncology information systems market accounted for the largest market share in 2020, owing to the such as the rising prevalence of cancer and the availability of advanced healthcare infrastructure.
According to the American Society of Clinical Oncology estimates, there were around 42,220 adults diagnosed with liver cancer in the United States in 2018 (of which there are 30,610 men and 11,610 women). In addition, in 2020, there were around 42,810 new liver cancer cases in the United States 2020. With the increasing cases of cancer in the United States, it is expected to raise demand for oncology information systems to manage the disease.
The increasing R&D to develop patient-centric oncology information systems, rising prevalence of cancer, technological advancements in oncology information systems products and procedures are the key factors supporting market growth in North America. Most of the prominent companies in the global market are headquartered in the region or have a strong presence in this market.
On the other hand, Asia-Pacific is expected to exhibit the fastest growth rate over the forecast period due to the increase in healthcare expenditure, rising awareness about early diagnosis, high unmet clinical needs of patients, and effective treatment in emerging countries, such as China and India.
The oncology information systems market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Koninklijke Philips N.V., Varian Medical Systems Bayer, McKesson Corporation, Siemens Healthineers, Elekta AB, Epic Systems Corporation, IBM, Cerner Corporation, Advanced Data Systems, Bogardus Medical Systems, Inc, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the oncology information systems market globally.
Overview: Siemens Healthineers is a Germany-based company that provides technology to the healthcare sector companies. The Company has a wide range of products and services in laboratory and point of care diagnostics, diagnostic and therapeutic imaging and molecular medicine. It supplies medical technology and software solutions and clinical consulting services. Additionally, the Company is expanding its digital health and business services through increasing precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value.
Product Portfolio: The Company's portfolio comprised of medical imaging, laboratory diagnostics, point-of-care testing, and Healthcare IT, accessories and equipment's, and other areas.
Key Developments: In September 2020, Siemens Healthineers entered into a definitive agreement to acquire Varian Medical Systems. This acquisition will strengthen the company's existing portfolio of oncology information systems
The global oncology information systems market report would provide an access to an approx. 61 market data table, 51 figures and 200 pages.
LIST NOT EXHAUSTIVE